ClinicalTrials.gg
TerminatedNCT05441579Updated Dec 20, 2024Results posted

Recruitment and Behavioral Economic Strategies

An interventional study of Behavioral Economics (BE) recruitment strategies and Biofeedback-based virtual reality (VR-BF) in Surgery and Adolescent Behavior, sponsored by Vanessa Olbrecht. Terminated at 1 site in United States. Open to participants aged 12 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-20.

Sponsored by Vanessa Olbrecht · Not applicable, Interventional, and Health services research

How we know

Why this study was terminated
Interim analysis showed no difference between groups

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
128
Allocation
Randomized
Ages
12 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 165 studies in Adolescent Behavior with a site in United States — 20 open to participants now, 30 under way, none of them phase 3. Adolescent Behavior · United States.

Enrollment
88th of 150
128 · median 171
Started
2022
with 22 others
No phase
140 of 165
17 open now
Registered
122nd of 165
by date

Among the 165 studies in Adolescent Behavior with a site in United States, this one is the 88th largest by enrollment of the 150 interventional ones that give a count, is one of 23 that started in 2022, is one of 140 with no phase, and was the 122nd registered.

Adolescent Behavior

306 studies on the registry are indexed under Adolescent Behavior; 48 are open to participants now.

Browse Adolescent Behavior studies →

Open to participants now

20 of the 165 studies in Adolescent Behavior with a site in United States are open now. Recruiting first, the newest first:

15 more — sign in →

All 20 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 30 Adolescent Behavior studies recruiting now, 8 (27%) set no upper age limit and 22 (73%) stop at 75 or younger; 29 take children under 18; 16 take healthy volunteers.

This study: 12 Years to 18 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 165 studies in Adolescent Behavior with a site in United States, or all of them as a file.
02

Study summary

To determine the impact of the application of behavioral economic strategies on recruitment of pediatric patients into a randomized clinical trial assessing the impact of technology-based interventions on postoperative pain management.

Read the detailed description

Patients will be asked to watch one of two videos in either Phase 1 or Phase 2 relating to recruitment and fill out a survey to determine their likelihood to enroll in a research study. Patients 12-18 years of age presenting for surgery that requires postoperative admission and usually requires narcotic administration.

03

Conditions studied

  • Surgery
  • Adolescent Behavior

Browse trials for

04

Who can participate

Ages eligible
12 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients between the ages of 12-18 years of age
  • Patients able to read, understand, and speak English
  • Patients undergoing surgery requiring postoperative admission
  • Patients undergoing surgery that requires narcotic administration

Exclusion criteria

Exclusion Criteria:

  • Patients outside of the age range
  • Patients with history of developmental delay, uncontrolled psychiatric conditions, or neurological conditions (i.e., epilepsy, motion sickness, nausea/vomiting)
  • History of severe vertigo or dizziness
  • History of chronic pain
  • Patients that use opioids or benzodiazepines chronically
  • Patients with conditions that would preclude placement of a VR headset, including craniofacial abnormalities or undergoing surgeries of the head and neck.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Sequential assignment
Masking
Single (Participant)
Enrollment
128 participants (actual)

Study arms

  • Experimental
    Phase 1 - VR-BF BE

    We are applying Behavioral Economics (BE)-based messaging and presentation strategies to patient recruitment and determining whether these strategies may enhance patient recruitment into a pediatric randomized clinical trial. Phase 1 will focus on patients that would be enrolled into a biofeedback-based virtual reality (VR-BF) arm.

    Behavioral: Behavioral Economics (BE) recruitment strategies · Other: Biofeedback-based virtual reality (VR-BF)

  • Active comparator
    Phase 1 - VR-BF Biological

    A similar to BE-based recruitment video using a standard biological approach on teenagers' decision to enroll in a clinical study will be used as comparison. Phase 1 will focus on patients that would be enrolled into a biofeedback-based virtual reality (VR-BF) arm.

    Other: Biofeedback-based virtual reality (VR-BF)

  • Experimental
    Phase 2 - Manage My Pain BE

    We are applying Behavioral Economics (BE)-based messaging and presentation strategies to patient recruitment and determining whether these strategies may enhance patient recruitment into a pediatric randomized clinical trial. Phase 2 will focus on patients that would be enrolled into the control arm of a clinical trial with a control intervention, Manage My Pain application.

    Behavioral: Behavioral Economics (BE) recruitment strategies · Other: Manage My Pain

  • Placebo comparator
    Phase 2 - Manage My Pain Biological

    A similar to BE-based recruitment video using a standard biological approach on teenagers' decision to enroll in a clinical study will be used as comparison. Phase 2 will focus on patients that would be enrolled into the control arm of a clinical trial with a control intervention, Manage My Pain application.

    Other: Manage My Pain

Interventions

  • BehavioralBehavioral Economics (BE) recruitment strategies

    Behavioral economics (BE), a method of economic analysis that applies psychological insights into human behavior to explain economic decision-making, has broad applicability and its techniques offer a novel way that may be applied to try to help enhance study recruitment and enrollment.

  • OtherBiofeedback-based virtual reality (VR-BF)

    Phase 1 will focus on patients that would be enrolled into a biofeedback-based virtual reality (VR-BF) arm.

  • OtherManage My Pain

    Commercially available and free app to track, analyze and monitor pain.

06

What researchers measure

Primary outcomes

  1. To Determine the Impact of the Application of Behavioral Economic Strategies on Recruitment of Pediatric Patients Into a Randomized Clinical Trial Assessing the Impact of Technology-based Interventions on Postoperative Pain Management.

    Survey to identify likelihood to participate in study using a 5-point Likert scale (1="Extremely Unlikely" to 5="Extremely Likely").

    Time frame: Baseline

  2. Willingness to Participate in Clinical Trial

    If given the opportunity, would you participate in the clinical trial?

    Time frame: Baseline

Secondary outcomes

  1. Intention to Adhere to Therapy - Would Practice

    Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would practice this technology at least once per day before surgery.

    Time frame: Baseline

  2. Acceptability of Therapy - Excitement

    Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would be excited to use this technology.

    Time frame: Baseline

  3. Perception of Efficacy - Less Pain

    Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I believe this technology would help me have less pain after surgery.

    Time frame: Baseline

  4. Perception of Risk - Side Effects

    Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I am worried that this technology would have a lot of side effects.

    Time frame: Baseline

  5. Opinion of Treatment Burden - Ease of Use

    Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I feel that this technology would be easy to use.

    Time frame: Baseline

  6. Intention to Adhere to Therapy - Would Use

    Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would use this technology at least once per day after surgery while I was still needing it.

    Time frame: Baseline

  7. Acceptability of Therapy - Pain Medication

    Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would like to use this technology to help me take less pain medication.

    Time frame: Baseline

  8. Acceptability of Therapy - Recommend to Others

    Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would recommend this therapy to other individuals undergoing surgery.

    Time frame: Baseline

  9. Acceptability of Therapy - Preference

    Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would prefer using this technology over taking pain medications.

    Time frame: Baseline

  10. Perception of Efficacy - Less Pain Medication

    Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I believe that this technology would help me use less pain medication after surgery.

    Time frame: Baseline

  11. Perception of Risk - Amount

    Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I believe that this technology would be too risky for me to use.

    Time frame: Baseline

  12. Opinion of Treatment Burden - Independence

    Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would feel comfortable using this technology independently without supervision.

    Time frame: Baseline

  13. Opinion of Treatment Burden - Familiar

    Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I am familiar with how to use this type of technology.

    Time frame: Baseline

  14. Opinion of Treatment Burden - Pay for Technology

    Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would pay for the opportunity to use this technology during my recovery. I am comfortably using technologies like this.

    Time frame: Baseline

  15. Opinion of Treatment Burden - Technology Comfort

    Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I am comfortably using technologies like this.

    Time frame: Baseline

07

Results

Posted Dec 20, 2024

Participant flow

Participant flow — Overall Study
MilestonePhase 1 - VR-BF BEPhase 1 - VR-BF BiologicalPhase 2 - Manage My Pain BEPhase 2 - Manage My Pain Biological
Started646400
Completed646400
Not completed0000

Outcome measures

PrimaryTo Determine the Impact of the Application of Behavioral Economic Strategies on Recruitment of Pediatric Patients Into a Randomized Clinical Trial Assessing the Impact of Technology-based Interventions on Postoperative Pain Management.

Survey to identify likelihood to participate in study using a 5-point Likert scale (1="Extremely Unlikely" to 5="Extremely Likely").

Time frame:
Baseline
Reported as:
Median · score on a scale
To Determine the Impact of the Application of Behavioral Economic Strategies on Recruitment of Pediatric Patients Into a Randomized Clinical Trial Assessing the Impact of Technology-based Interventions on Postoperative Pain Management.
score on a scalePhase 1 - VR-BF BEPhase 1 - VR-BF Biological
Interest in using ForeVR4 (3 to 4)4 (3 to 4)
Interest in participating in clinical trial involving ForeVR3 (3 to 4)4 (3 to 4)
PrimaryWillingness to Participate in Clinical Trial

If given the opportunity, would you participate in the clinical trial?

Time frame:
Baseline
Reported as:
Count of participants · Participants
Willingness to Participate in Clinical Trial
ParticipantsPhase 1 - VR-BF BEPhase 1 - VR-BF Biological
Yes4849
No1613
SecondaryIntention to Adhere to Therapy - Would Practice

Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would practice this technology at least once per day before surgery.

Time frame:
Baseline
Reported as:
Median · score on a Likert scale
Intention to Adhere to Therapy - Would Practice
score on a Likert scalePhase 1 - VR-BF BEPhase 1 - VR-BF Biological
Intention to Adhere to Therapy - Would Practice4 (3 to 4)4 (3 to 4)
SecondaryAcceptability of Therapy - Excitement

Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would be excited to use this technology.

Time frame:
Baseline
Reported as:
Median · score on a Likert scale
Acceptability of Therapy - Excitement
score on a Likert scalePhase 1 - VR-BF BEPhase 1 - VR-BF Biological
Acceptability of Therapy - Excitement4 (3 to 4)4 (3 to 4)
SecondaryPerception of Efficacy - Less Pain

Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I believe this technology would help me have less pain after surgery.

Time frame:
Baseline
Reported as:
Median · score on a Likert scale
Perception of Efficacy - Less Pain
score on a Likert scalePhase 1 - VR-BF BEPhase 1 - VR-BF Biological
Perception of Efficacy - Less Pain3 (3 to 4)3 (3 to 4)
SecondaryPerception of Risk - Side Effects

Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I am worried that this technology would have a lot of side effects.

Time frame:
Baseline
Reported as:
Median · score on a Likert scale
Perception of Risk - Side Effects
score on a Likert scalePhase 1 - VR-BF BEPhase 1 - VR-BF Biological
Perception of Risk - Side Effects2 (1 to 2)2 (2 to 3)
SecondaryOpinion of Treatment Burden - Ease of Use

Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I feel that this technology would be easy to use.

Time frame:
Baseline
Reported as:
Median · score on a Likert scale
Opinion of Treatment Burden - Ease of Use
score on a Likert scalePhase 1 - VR-BF BEPhase 1 - VR-BF Biological
Opinion of Treatment Burden - Ease of Use3 (3 to 4)4 (3 to 4)
SecondaryIntention to Adhere to Therapy - Would Use

Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would use this technology at least once per day after surgery while I was still needing it.

Time frame:
Baseline
Reported as:
Median · score on a Likert scale
Intention to Adhere to Therapy - Would Use
score on a Likert scalePhase 1 - VR-BF BEPhase 1 - VR-BF Biological
Intention to Adhere to Therapy - Would Use4 (3 to 4)4 (3 to 4)
SecondaryAcceptability of Therapy - Pain Medication

Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would like to use this technology to help me take less pain medication.

Time frame:
Baseline
Reported as:
Median · score on a Likert scale
Acceptability of Therapy - Pain Medication
score on a Likert scalePhase 1 - VR-BF BEPhase 1 - VR-BF Biological
Acceptability of Therapy - Pain Medication4 (3 to 4)4 (3 to 4)
SecondaryAcceptability of Therapy - Recommend to Others

Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would recommend this therapy to other individuals undergoing surgery.

Time frame:
Baseline
Reported as:
Median · score on a Likert scale
Acceptability of Therapy - Recommend to Others
score on a Likert scalePhase 1 - VR-BF BEPhase 1 - VR-BF Biological
Acceptability of Therapy - Recommend to Others4 (3 to 4)4 (3 to 4)
SecondaryAcceptability of Therapy - Preference

Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would prefer using this technology over taking pain medications.

Time frame:
Baseline
Reported as:
Median · score on a Likert scale
Acceptability of Therapy - Preference
score on a Likert scalePhase 1 - VR-BF BEPhase 1 - VR-BF Biological
Acceptability of Therapy - Preference4 (3 to 4)4 (3 to 4)
SecondaryPerception of Efficacy - Less Pain Medication

Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I believe that this technology would help me use less pain medication after surgery.

Time frame:
Baseline
Reported as:
Median · score on a Likert scale
Perception of Efficacy - Less Pain Medication
score on a Likert scalePhase 1 - VR-BF BEPhase 1 - VR-BF Biological
Perception of Efficacy - Less Pain Medication3 (3 to 4)3 (3 to 4)
SecondaryPerception of Risk - Amount

Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I believe that this technology would be too risky for me to use.

Time frame:
Baseline
Reported as:
Median · score on a Likert scale
Perception of Risk - Amount
score on a Likert scalePhase 1 - VR-BF BEPhase 1 - VR-BF Biological
Perception of Risk - Amount2 (1 to 2)2 (2 to 3)
SecondaryOpinion of Treatment Burden - Independence

Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would feel comfortable using this technology independently without supervision.

Time frame:
Baseline
Reported as:
Median · score on a Likert scale
Opinion of Treatment Burden - Independence
score on a Likert scalePhase 1 - VR-BF BEPhase 1 - VR-BF Biological
Opinion of Treatment Burden - Independence3 (3 to 4)4 (3 to 4)
SecondaryOpinion of Treatment Burden - Familiar

Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I am familiar with how to use this type of technology.

Time frame:
Baseline
Reported as:
Median · score on a Likert scale
Opinion of Treatment Burden - Familiar
score on a Likert scalePhase 1 - VR-BF BEPhase 1 - VR-BF Biological
Opinion of Treatment Burden - Familiar3 (3 to 4)4 (3 to 4)
SecondaryOpinion of Treatment Burden - Pay for Technology

Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I would pay for the opportunity to use this technology during my recovery. I am comfortably using technologies like this.

Time frame:
Baseline
Reported as:
Median · score on a Likert scale
Opinion of Treatment Burden - Pay for Technology
score on a Likert scalePhase 1 - VR-BF BEPhase 1 - VR-BF Biological
Opinion of Treatment Burden - Pay for Technology3 (3 to 4)4 (3 to 4)
SecondaryOpinion of Treatment Burden - Technology Comfort

Based on answers to the following survey questions which were assessed along a 5-point Likert scale (from 1="Strongly Disagree" to 5= "Strongly Agree"): I am comfortably using technologies like this.

Time frame:
Baseline
Reported as:
Median · score on a Likert scale
Opinion of Treatment Burden - Technology Comfort
score on a Likert scalePhase 1 - VR-BF BEPhase 1 - VR-BF Biological
Opinion of Treatment Burden - Technology Comfort3 (3 to 4)4 (3 to 4)

Adverse events

Collected over 1 day. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Phase 1 - VR-BF BE0/64 (0%)0/64 (0%)0/64 (0%)
Phase 1 - VR-BF Biological0/64 (0%)0/64 (0%)0/64 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Phase 1 - VR-BF BEPhase 1 - VR-BF BiologicalTotal
Mean14.7 ± 1.614.6 ± 1.614.7 ± 1.6
Sex/Gender, Customized
Sex/Gender, Customized(Participants)Phase 1 - VR-BF BEPhase 1 - VR-BF BiologicalTotal
Male313364
Female323163
Prefer not to answer101
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Phase 1 - VR-BF BEPhase 1 - VR-BF BiologicalTotal
Hispanic or Latino437
Not Hispanic or Latino6061121
Unknown or Not Reported000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Phase 1 - VR-BF BEPhase 1 - VR-BF BiologicalTotal
American Indian or Alaska Native123
Asian516
Native Hawaiian or Other Pacific Islander000
Black or African American8513
White5053103
More than one race022
Unknown or Not Reported011
Region of Enrollment
Region of Enrollment(participants)Phase 1 - VR-BF BEPhase 1 - VR-BF BiologicalTotal
United States6464128
Previous pain management
Previous pain management(Participants)Phase 1 - VR-BF BEPhase 1 - VR-BF BiologicalTotal
Over-the-counter pain medication5958117
Massage71320
Acupuncture112
Chiropractor6410
Prescribed pain medication132033
Deep breathing, meditation, guided imagery, relaxation or similar approach91625
Have not had pain in the past000
Other347
08

Study locations

1 site
  • Nationwide Children's Hospital
    Columbus, Ohio 43205, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from May 2022 to primary completion in Sep 2022, 3 months.

Results were first posted in Dec 2024, 2 years 3 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 28, 2022
First posted
Jul 1, 2022
StartActual
May 17, 2022
Primary completionActual
Sep 8, 2022
CompletionActual
Sep 8, 2022
Results first posted
Dec 20, 2024
Last update
Dec 20, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05441579
Lead sponsor
Vanessa Olbrecht
Responsible party
Vanessa Olbrecht (Associate Professor of Anesthesiology, Nationwide Children's Hospital) — Sponsor-investigator
First posted
Jul 1, 2022
Start date
May 17, 2022
Primary completion
Sep 8, 2022
Completion
Sep 8, 2022
Results posted
Dec 20, 2024
Last update
Dec 20, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion